Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome-Reference-Cited by-同舟云学术

Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome

Published:2022-04 Issue:4 Volume:33 Page:
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatric Allergy Immunology

Author:

Matucci‐Cerinic Caterina¹²^ORCID,Viglizzo Gianmaria³,Pastorino Carlotta³,Corcione Anna²,Prigione Ignazia²,Bocca Paola²,Bustaffa Marta¹²,Cecconi Massimiliano⁴,Gattorno Marco²⁵,Volpi Stefano¹²

Affiliation:

1. Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno‐Infantili (DINOGMI) Università degli Studi di Genova Genova Italy

2. Unità Operativa Semplice Dipartimentale Centro Malattie Autoinfiammatorie e Immunodeficienze IRCCS Istituto Giannina Gaslini Genova Italy

3. UOC Dermatologia IRCCS Istituto Giannina Gaslini Genoa Italy

4. UOC laboratorio di Genetica umana IRCCS Istituto Giannina Gaslini Genoa Italy

5. UOC Clinica Pediatrica e Reumatologia IRCCS Istituto Giannina Gaslini Genoa Italy

Publisher

Wiley

Subject

Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pai.13770

Reference10 articles.

1. STAT3Mutations in the Hyper-IgE Syndrome

2. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

3. Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome

4. Treatment of severe atopic dermatitis and eosinophilic esophagitis with dupilumab in a 14-year-old boy with autosomal dominant hyper-IgE syndrome

5. Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyper IgE Syndromes;Current Pediatric Reviews;2024-08

2. Monogenic Inborn Errors of Immunity with impaired IgG response to polysaccharide antigens but normal IgG levels and normal IgG response to protein antigens;Frontiers in Pediatrics;2024-06-12

3. Management of Atopy with Dupilumab and Omalizumab in CADINS Disease;Journal of Clinical Immunology;2024-01-17

4. The treatment efficacy of dupilumab in autosomal dominant hyper-immunoglobulin E syndrome with severe atopic dermatitis;Asia Pacific Allergy;2023-10-09

5. ERBIN and phosphoglucomutase 3 deficiency;Current Opinion in Immunology;2023-10